Apoptosis-driven clearance of senescent cells (senolytic activity)
Senolytic Cell Clearance · Metabolic sensing, autophagy and longevity
Briefly inhibits the pro-survival network characteristic of senescent cells (the SCAP pathways), pushing the “zombie cells” that release pro-inflammatory SASP toxins into programmed cell death (apoptosis).
Supplements acting on this mechanism (ranked by strength and evidence)
Fisetin
Fisetin showed potential to clear senescent cells in some cell models and in high-dose mouse experiments, where markers of senescence fell in some fat tissues. Selective clearance of senescent cells in humans has not been confirmed. The animal doses were high and should not be extrapolated to typical supplement doses.
Piperlongumine
In some senescent-cell experiments, piperlongumine can preferentially kill senescent cells, and related studies suggest that OXR1, among other factors, may be involved. The mechanism and specific targets of selective clearance are not yet fully established, and there is no reliable study of clearance in humans after oral intake.
Quercetin
Studies pairing dasatinib with quercetin to clear senescent cells are still exploratory, and the results cannot be attributed to quercetin alone. The selective senolytic effect of quercetin alone comes mainly from cell experiments and has not been established.
Apigenin
In cell and mouse studies, apigenin reduced the senescence-associated secretory phenotype (SASP) and lowered the output of pro-inflammatory cytokines. But suppressing the secretory phenotype is not the same as clearing senescent cells, and there is currently no reliable evidence that apigenin selectively clears senescent cells.
Luteolin
In cell experiments, luteolin can reduce senescence phenotypes induced by oxidative stress, but that is not the same as clearing senescent cells. There is currently no reliable human or whole-animal evidence that it selectively induces apoptosis in senescent cells.